The aim of this study is to investigate the predictive dimension of cognitive-emotional status of cancer patients on the chronic pain development 6 months after different cancer treatment protocol (surgery, chemotherapy, radiotherapy, hormone therapy, targeted therapy ...).
This is an observational, longitudinal and multicenter study assessing in cancer patients the link between the cognitive-emotional status and the development of chronic pain. Cognition, anxiety, depression, quality of life, social vulnerability, cancer perception, pain and analgesic consumption are assessed.
Study Type
OBSERVATIONAL
Enrollment
89
CHU Clermont-Ferrand
Clermont-Ferrand, France
Measure of average pain intensity by a numerical rating scale
Measure of average pain intensity by a numerical rating scale assessed 7 days before the 6 months visit after inclusion of patients.
Time frame: 7 days before the visit
Pain assessment by numerical rating scale and DN4
Time frame: at baseline
Pain assessment by numerical rating scale and DN4
Time frame: at 6 months
Pain assessment by numerical rating scale and DN4
Time frame: at 12 months
Pain assessment by numerical rating scale and DN4
Time frame: at 24 months
Pain assessment by numerical rating scale and DN4
Time frame: 2 days after each cancer treatment protocol
Evaluation of analgesic consumption
Analgesic consumption is evaluated during all period of the study (name of the specialty, dose, indication, form, administration route, starting date, end date),
Time frame: at day 1
Cognitive assessment by Trail Making Test A and B (TMT)
Time frame: at baseline
Cognitive assessment by Trail Making Test A and B (TMT)
Time frame: at 24 months
Cognitive assessment by Trail Making Test A and B (TMT)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: at 6 months
Cognitive assessment by Trail Making Test A and B (TMT)
Time frame: at 12 months
Rey Auditory-Verbal Learning Test (RAVLT) and FACT-COG
Time frame: at baseline
Rey Auditory-Verbal Learning Test (RAVLT) and FACT-COG
Time frame: at 24 months
Rey Auditory-Verbal Learning Test (RAVLT) and FACT-COG
Time frame: at 12 months
Rey Auditory-Verbal Learning Test (RAVLT) and FACT-COG
Time frame: at 6 months
Quality of life assessment
Quality of life assessment by: \- The European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30), at baseline, 6 months, 12 months and 24 months. This questionnaire assesses the quality of life of cancer patients. It is divided in 9 subscales consisting of several items: 5 subscales measuring functional status (physical, role, social, emotional, cognitive), three subscales measuring symptoms (fatigue, pain, nausea and vomiting) and a global subscale of quality of life and health. Finally, six items/isolated symptoms, covering cancer symptoms and frequent side effects of cancer therapies (e.g. loss of appetite) are also included in the EORTC QLQ-C30. The EORTC QLQ-C30 Score ranges from 0 to 126
Time frame: at baseline, 6 months, 12 months and 24 months,
Social vulnerability assessment by EPICES questionnaire
Time frame: at baseline, 6 months, 12 months and 24 months
Anxiety and Depression assessment by HAD scale
Time frame: at baseline, 6 months, 12 months and 24 months
Illness perception assessment
Global score ranges from 0 to 200
Time frame: at baseline, 6 months, 12 months and 24 months
Coping strategies assessment by Coping strategies questionnaire (CSQ)
Time frame: 2 days after each cancer treatment protocol.